Concentrix (NASDAQ:CNXC) Issues Quarterly Earnings Results, Misses Expectations By $0.01 EPS

Concentrix (NASDAQ:CNXCGet Free Report) issued its quarterly earnings results on Monday. The company reported $2.63 EPS for the quarter, missing the consensus estimate of $2.64 by ($0.01), FiscalAI reports. The company had revenue of $2.46 billion during the quarter, compared to analysts’ expectations of $2.47 billion. Concentrix had a positive return on equity of 17.80% and a negative net margin of 13.35%. Concentrix updated its FY 2026 guidance to 10.830-11.180 EPS and its Q3 2026 guidance to 2.650-2.770 EPS.

Concentrix Price Performance

Shares of CNXC stock traded up $0.23 during midday trading on Monday, reaching $25.23. 3,589,207 shares of the company traded hands, compared to its average volume of 1,621,175. The firm’s 50 day simple moving average is $25.93 and its two-hundred day simple moving average is $32.17. The firm has a market cap of $1.54 billion, a PE ratio of -1.17, a price-to-earnings-growth ratio of 0.31 and a beta of 0.43. The company has a debt-to-equity ratio of 1.43, a current ratio of 1.18 and a quick ratio of 1.18. Concentrix has a 1-year low of $22.05 and a 1-year high of $62.14.

Analyst Ratings Changes

CNXC has been the subject of a number of research reports. Canaccord Genuity Group cut their target price on shares of Concentrix from $80.00 to $55.00 and set a “buy” rating for the company in a research note on Wednesday, March 25th. Robert W. Baird reduced their target price on Concentrix from $52.00 to $40.00 and set an “outperform” rating for the company in a report on Wednesday, March 25th. Wall Street Zen lowered Concentrix from a “buy” rating to a “hold” rating in a research note on Saturday, March 28th. Weiss Ratings reissued a “sell (d)” rating on shares of Concentrix in a research note on Monday, April 27th. Finally, Barrington Research reiterated an “outperform” rating and issued a $38.00 target price on shares of Concentrix in a research report on Monday, June 22nd. Three investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $44.33.

Check Out Our Latest Research Report on Concentrix

Insider Activity at Concentrix

In other news, CFO Andre S. Valentine purchased 2,500 shares of the business’s stock in a transaction dated Thursday, April 9th. The stock was acquired at an average price of $27.95 per share, with a total value of $69,875.00. Following the purchase, the chief financial officer directly owned 89,066 shares of the company’s stock, valued at $2,489,394.70. This represents a 2.89% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, major shareholder Bruxelles Lambert Groupe sold 6,000,000 shares of the business’s stock in a transaction dated Wednesday, April 29th. The stock was sold at an average price of $22.25, for a total transaction of $133,500,000.00. Following the completion of the sale, the insider owned 2,773,667 shares in the company, valued at $61,714,090.75. This represents a 68.39% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 0.90% of the company’s stock.

Hedge Funds Weigh In On Concentrix

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. AQR Capital Management LLC lifted its holdings in shares of Concentrix by 1.8% in the third quarter. AQR Capital Management LLC now owns 4,380,821 shares of the company’s stock valued at $202,175,000 after purchasing an additional 75,352 shares in the last quarter. Dimensional Fund Advisors LP raised its position in shares of Concentrix by 28.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 2,491,270 shares of the company’s stock worth $103,588,000 after purchasing an additional 551,778 shares during the last quarter. State Street Corp lifted its stake in Concentrix by 8.7% in the 2nd quarter. State Street Corp now owns 1,622,854 shares of the company’s stock valued at $85,776,000 after buying an additional 130,529 shares in the last quarter. First Trust Advisors LP grew its holdings in Concentrix by 37.7% during the 4th quarter. First Trust Advisors LP now owns 805,898 shares of the company’s stock valued at $33,509,000 after buying an additional 220,590 shares during the last quarter. Finally, Bank of New York Mellon Corp grew its holdings in Concentrix by 157.1% during the 4th quarter. Bank of New York Mellon Corp now owns 709,770 shares of the company’s stock valued at $29,512,000 after buying an additional 433,731 shares during the last quarter. Institutional investors and hedge funds own 90.34% of the company’s stock.

Concentrix Company Profile

(Get Free Report)

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.

Recommended Stories

Earnings History for Concentrix (NASDAQ:CNXC)

Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.